224 related articles for article (PubMed ID: 17194167)
21. Isotretinoin-induced skin fragility in a teenaged athlete: a case report.
Pavlis MB; Lieblich L
Cutis; 2013 Jul; 92(1):33-4. PubMed ID: 23961523
[TBL] [Abstract][Full Text] [Related]
22. Family physicians and accutane.
Van Durme DJ
Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
[No Abstract] [Full Text] [Related]
23. Simplifying contraception requirements for iPLEDGE: A decision analysis.
Barbieri JS; Roe AH; Mostaghimi A
J Am Acad Dermatol; 2020 Jul; 83(1):104-108. PubMed ID: 32068040
[TBL] [Abstract][Full Text] [Related]
24. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
[TBL] [Abstract][Full Text] [Related]
25. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.
Barbieri JS; Frieden IJ; Nagler AR
JAMA Dermatol; 2020 Jan; 156(1):21-22. PubMed ID: 31664426
[No Abstract] [Full Text] [Related]
26. A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers.
Singer S; Keuroghlian AS
LGBT Health; 2020 Jul; 7(5):216-219. PubMed ID: 32456537
[TBL] [Abstract][Full Text] [Related]
27. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
Stobaugh DJ; Deepak P; Ehrenpreis ED
J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
[TBL] [Abstract][Full Text] [Related]
28. Isotretinoin in Denmark -- 20 years on.
Wildfang IL; Nielsen NH; Jemec GB; Ibsen HH; Avnstorp C
J Dermatolog Treat; 2002 Sep; 13(3):151-2. PubMed ID: 12227880
[No Abstract] [Full Text] [Related]
29. Safety and side effects of the acne drug, oral isotretinoin.
Charakida A; Mouser PE; Chu AC
Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
[TBL] [Abstract][Full Text] [Related]
30. Depression is not common in isotretinoin-treated acne patients.
Rohrback JM; Fleischer AB; Krowchuk DP; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):252. PubMed ID: 15764041
[No Abstract] [Full Text] [Related]
31. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
Rademaker M
Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
[TBL] [Abstract][Full Text] [Related]
32. Safety issues in isotretinoin therapy.
Hanson N; Leachman S
Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
[TBL] [Abstract][Full Text] [Related]
33. Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.
Honein MA; Moore CA; Erickson JD
Drug Saf; 2004; 27(14):1069-80. PubMed ID: 15554743
[TBL] [Abstract][Full Text] [Related]
34. Low dose of isotretinoin: A comprehensive review.
Abdelmaksoud A; Lotti T; Anadolu R; Goldust M; Ayhan E; Dave DD; Vestita M; Ebik B; Gupta M
Dermatol Ther; 2020 Mar; 33(2):e13251. PubMed ID: 32022958
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects of isotretinoin therapy for acne vulgaris.
Lamb SR; Oakley AM
N Z Med J; 2001 Sep; 114(1139):414. PubMed ID: 11665936
[No Abstract] [Full Text] [Related]
36. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
37. Isotretinoin and the risk of depression.
Thakrar BT; Robinson NJ
J Clin Psychiatry; 2009 Oct; 70(10):1475; author reply 1475-6. PubMed ID: 19906352
[No Abstract] [Full Text] [Related]
38. Isotretinoin updates.
On SC; Zeichner J
Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
[TBL] [Abstract][Full Text] [Related]
39. Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
Mostow EN
Arch Dermatol; 2011 Jun; 147(6):729-30. PubMed ID: 21690538
[No Abstract] [Full Text] [Related]
40. Possible long-term teratogenic effect of isotretinoin in pregnancy.
Malvasi A; Tinelli A; Buia A; De Luca GF
Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
